Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2023;91(3):1059-1071.
doi: 10.3233/JAD-220535.

Obesity-Associated Neurodegeneration Pattern Mimics Alzheimer's Disease in an Observational Cohort Study

Filip Morys  1 , Olivier Potvin  2 , Yashar Zeighami  1   3 , Jacob Vogel  1 , Rémi Lamontagne-Caron  2 , Simon Duchesne  2   4 , Alain Dagher  1 ; Alzheimer’s Disease Neuroimaging Initiative
Affiliations
Observational Study

Obesity-Associated Neurodegeneration Pattern Mimics Alzheimer's Disease in an Observational Cohort Study

Filip Morys et al. J Alzheimers Dis. 2023.

Abstract

Background: Excess weight in adulthood leads to health complications such as diabetes, hypertension, or dyslipidemia. Recently, excess weight has also been related to brain atrophy and cognitive decline. Reports show that obesity is linked with Alzheimer's disease (AD)-related changes, such as cerebrovascular damage or amyloid-β accumulation. However, to date no research has conducted a direct comparison between brain atrophy patterns in AD and obesity.

Objective: Here, we compared patterns of brain atrophy and amyloid-β/tau protein accumulation in obesity and AD using a sample of over 1,300 individuals from four groups: AD patients, healthy controls, obese otherwise healthy individuals, and lean individuals.

Methods: We age- and sex-matched all groups to the AD-patients group and created cortical thickness maps of AD and obesity. This was done by comparing AD patients with healthy controls, and obese individuals with lean individuals. We then compared the AD and obesity maps using correlation analyses and permutation-based tests that account for spatial autocorrelation. Similarly, we compared obesity brain maps with amyloid-β and tau protein maps from other studies.

Results: Obesity maps were highly correlated with AD maps but were not correlated with amyloid-β/tau protein maps. This effect was not accounted for by the presence of obesity in the AD group.

Conclusion: Our research confirms that obesity-related grey matter atrophy resembles that of AD. Excess weight management could lead to improved health outcomes, slow down cognitive decline in aging, and lower the risk for AD.

Keywords: Alzheimer’s disease; grey matter; neurodegeneration; obesity.

PubMed Disclaimer

Conflict of interest statement

Authors’ disclosures available online (https://www.j-alz.com/manuscript-disclosures/22-0535r2).

Figures

Fig. 1
Fig. 1
Matching algorithm for a) full sample; b) sample of lean patients with Alzheimer’s disease (AD); c) sample of obese patients with AD. HC, healthy controls; BMI, body mass index
Fig. 2
Fig. 2
Brain maps of a) Alzheimer’s disease (AD) and obesity in the full sample; b) AD and obesity in the sample of lean AD patients and other matched samples; c) AD and obesity in the sample of obese AD patients and other matched samples. Color bars depict β estimates.
Fig. 3
Fig. 3
Brain map of absolute values of rank differences between AD and obesity cortical-thickness maps. Lower values represent higher rank similarity of the parcels, depicting regions of highest similarity between AD and obesity.
See this image and copyright information in PMC

Comment in

  • Adipositas lässt Hirnrinde schrumpfen.
    Dodel R. Dodel R. MMW Fortschr Med. 2023 Sep;165(16):28. doi: 10.1007/s15006-023-2953-5. MMW Fortschr Med. 2023. PMID: 37710105 Review. German. No abstract available.

References

    1. Sarma S, Sockalingam S, Dash S (2021) Obesity as a multisystem disease: Trends in obesity rates and obesity-related complications. Diabetes Obes Metab 23, 3–16. - PubMed
    1. Aggoun Y (2007) Obesity, metabolic syndrome, and cardiovascular disease. Pediatr Res 61, 653–659. - PubMed
    1. Deckers K, van Boxtel MPJ, Verhey FRJ, Köhler S (2017) Obesity and cognitive decline in adults: Effect of methodological choices and confounding by age in a longitudinal study. J Nutr Health Aging 21, 546–553. - PubMed
    1. Morys F, Dadar M, Dagher A (2021) Association between mid-life obesity, its metabolic consequences, cerebrovascular disease and cognitive decline. J Clin Endocrinol Metab 106, e4260–e4274. - PMC - PubMed
    1. Harrington KD, Dang C, Lim YY, Ames D, Laws SM, Pietrzak RH, Rainey-Smith S, Robertson J, Rowe CC, Salvado O, Villemagne VL, Masters CL, Maruff P (2018) The effect of preclinical Alzheimer’s disease on age-related changes in intelligence in cognitively normal older adults. Intelligence 70, 22–29.

Publication types

LinkOut - more resources